Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple operations for recurrent colorectal cancer.

A Sardi1

  • 1Department of Surgery, Ochsner Clinic, New Orleans, Louisiana 70121.

Seminars in Surgical Oncology
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recurrence Incidence and Optimal Surveillance After Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Mucinous Appendix Cancer.

Annals of surgical oncology·2025
Same author

Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI).

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2020
Same author

Approach to the Porta Hepatis During Cytoreductive Surgery: Technical Considerations.

Annals of surgical oncology·2015
Same author

Extensive surgical history prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with poor survival outcomes in patients with peritoneal mucinous carcinomatosis of appendiceal origin.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2015
Same author

Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA).

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2015
Same author

Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei.

The British journal of surgery·2014
Same journal

Preoperative chemoradiation for locally advanced rectal cancer: rationale, technique, and results of treatment.

Seminars in surgical oncology·2003
Same journal

Preoperative chemoradiation for locally advanced rectal adenocarcinoma-the University of Florida experience.

Seminars in surgical oncology·2003
Same journal

Postoperative adjuvant therapy for pancreatic cancer.

Seminars in surgical oncology·2003
Same journal

Conformal chemoradiation for primary and metastatic liver malignancies.

Seminars in surgical oncology·2003
Same journal

Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer.

Seminars in surgical oncology·2003
Same journal

Combined modality therapy in esophageal cancer: the Memorial experience.

Seminars in surgical oncology·2003
See all related articles

Aggressive surgery offers significant survival benefits for select patients with recurrent colorectal cancer. Identifying ideal candidates through tumor biology analysis is crucial for optimizing outcomes.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Cancer Biology

Background:

  • Recurrent colorectal cancer presents a significant clinical challenge.
  • Previous studies suggest potential benefits of aggressive surgical intervention.

Purpose of the Study:

  • To evaluate the efficacy of aggressive surgical approaches in patients with recurrent colorectal cancer.
  • To identify patient-specific factors that predict benefit from radical surgery.

Main Methods:

  • Review of existing literature on surgical management of recurrent colorectal cancer.
  • Analysis of disease-free survival rates in patients undergoing aggressive surgery.
  • Exploration of tumor differentiation, DNA, and oncogene analysis for patient selection.

Related Experiment Videos

Main Results:

  • Disease-free 5-year survival rates range from 30% to as high as 46% in selected cases.
  • Aggressive surgical procedures can be performed with acceptable morbidity and mortality in experienced hands.
  • Tumor biology markers show promise in identifying patients likely to benefit.

Conclusions:

  • Aggressive surgical resection is a viable option for carefully selected patients with recurrent colorectal cancer.
  • Further research into tumor biology markers is essential for refining patient selection criteria.
  • Optimizing surgical outcomes requires experienced surgical teams and precise patient stratification.